Trial of next-gen weight-loss drug retatrutide brings it one step closer to FDA approval
[RSS: www.scientificamerican.com] While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
Trial of next-gen weight-loss drug retatrutide brings it one step closer to FDA approval
[RSS: www.scientificamerican.com] While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
[RSS: www.scientificamerican.com] While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
Admin
Editor
Comments (0)
No comments yet. Be the first to share your thoughts!